Comparative Hepatitis B Vaccine study

Why are we doing this study: The Comparative Hepatitis B Vaccine study is evaluating the safety and effectiveness of a newer Hepatitis B vaccine against the currently approved Hepatitis B vaccine. This will be a randomized multi-site clinical trial involving adults age 18 years and older.

The study involves: The participants of this study will receive 3 doses of the approved vaccine or the study vaccine over 3 visits. Blood tests will be taken at all visits. There will be a total of 7-10 visits over a 12 month period.